| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,533 |
25,431 |
$1.85M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,011 |
22,580 |
$858K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,657 |
2,731 |
$345K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,834 |
5,774 |
$280K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,046 |
4,624 |
$256K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,041 |
4,422 |
$253K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,956 |
4,408 |
$245K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,934 |
2,628 |
$152K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,372 |
2,048 |
$107K |
| 90686 |
|
6,268 |
5,405 |
$67K |
| 90670 |
|
3,365 |
3,163 |
$36K |
| 90723 |
|
2,457 |
2,279 |
$26K |
| 90647 |
|
2,123 |
1,990 |
$25K |
| 99173 |
|
1,893 |
1,728 |
$23K |
| 87428 |
|
274 |
257 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,306 |
1,194 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,305 |
1,061 |
$14K |
| 90633 |
|
1,236 |
1,127 |
$13K |
| 87449 |
|
979 |
902 |
$12K |
| 92551 |
|
1,426 |
1,292 |
$11K |
| 90707 |
|
1,063 |
975 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
261 |
252 |
$11K |
| 90716 |
|
1,042 |
952 |
$11K |
| 87634 |
|
153 |
130 |
$11K |
| 0071A |
|
124 |
112 |
$10K |
| 90681 |
|
933 |
847 |
$10K |
| 0072A |
|
105 |
95 |
$9K |
| 90734 |
|
757 |
688 |
$9K |
| 90651 |
|
676 |
629 |
$8K |
| 90648 |
|
500 |
417 |
$6K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
140 |
122 |
$6K |
| 90656 |
|
571 |
328 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,370 |
7,978 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
166 |
118 |
$4K |
| 96127 |
|
3,295 |
2,330 |
$4K |
| 90677 |
|
335 |
262 |
$3K |
| 81000 |
|
767 |
652 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
32 |
29 |
$3K |
| 90715 |
|
201 |
189 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
35 |
26 |
$2K |
| 90696 |
|
199 |
173 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
115 |
97 |
$2K |
| 85018 |
|
299 |
276 |
$882.34 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
34 |
32 |
$821.42 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
12 |
$799.35 |
| 83655 |
|
47 |
45 |
$743.04 |
| 90700 |
|
55 |
51 |
$643.86 |
| 90685 |
|
68 |
66 |
$611.84 |
| 71020 |
|
13 |
13 |
$486.20 |
| 74018 |
|
12 |
12 |
$397.39 |
| 86318 |
|
16 |
13 |
$240.37 |
| 94760 |
|
61 |
43 |
$157.30 |
| 36415 |
Collection of venous blood by venipuncture |
66 |
65 |
$136.86 |
| 99051 |
|
777 |
695 |
$82.16 |
| 94664 |
|
30 |
27 |
$69.50 |
| 99070 |
|
17 |
14 |
$10.00 |
| 91307 |
|
231 |
213 |
$1.94 |
| 96160 |
|
249 |
225 |
$0.00 |
| 99177 |
|
31 |
29 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
48 |
24 |
$0.00 |
| 99072 |
|
30 |
28 |
$0.00 |
| G9920 |
Screening performed and negative |
26 |
26 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
48 |
46 |
$0.00 |
| 96161 |
|
606 |
556 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
50 |
40 |
$0.00 |
| 99000 |
|
1,477 |
1,310 |
$0.00 |